The association of skeletal muscle mass and cisplatin pharmacokinetics in head and neck cancer patients: The prospective PLATISMA study.

被引：1
|
作者：
Molenaar-Kuijsten, Laura
Chargi, Najiba
Devriese, Lot
de Bree, Remco
Huitema, Alwin
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Head & Neck Surg Oncol, Utrecht, Netherlands
[5] Netherlands Canc Inst Antoni van Leeuwenhoek, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.6021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6021
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The association of cisplatin pharmacokinetics and skeletal muscle mass in patients with head and neck cancer: The prospective PLATISMA study
    Chargi, Najiba
    Molenaar-Kuijsten, Laura
    Huiskamp, Laura F. J.
    Devriese, Lot A.
    de Bree, Remco
    Huitema, Alwin D. R.
    EUROPEAN JOURNAL OF CANCER, 2022, 160 : 92 - 99
  • [2] Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer
    Jung, Ah Ra
    Roh, Jong-Lyel
    Kim, Jae Seung
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    ORAL ONCOLOGY, 2019, 95 : 95 - 99
  • [3] Skeletal muscle mass measurements using head and neck CT imaging in head and neck cancer patients
    de Bree, Remco
    Swartz, Justin E.
    Bril, Sandra
    Chargi, Najiba
    Wegner, Inge
    Smid, Ernst J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 72 - 73
  • [4] Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer
    Chang, Sheng-Wei
    Tsai, Yuan-Hsiung
    Hsu, Cheng-Ming
    Huang, Ethan I.
    Chang, Geng-He
    Tsai, Ming-Shao
    Tsai, Yao-Te
    PLOS ONE, 2021, 16 (05):
  • [5] How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study
    Anouk W. M. A. Schaeffers
    Maartje A. van Beers
    Lot A. Devriese
    F. W. José Klomp
    Chantal F. M. Westerink - van den Brink
    Ernst J. Smid
    Remco de Bree
    Caroline M. Speksnijder
    Supportive Care in Cancer, 2024, 32 (11)
  • [6] Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy
    Suzuki, Satoshi
    Yokota, Tomoya
    Notsu, Akifumi
    Hamauchi, Satoshi
    Onozawa, Yusuke
    Fushiki, Kunihiro
    Oshima, Kotoe
    Kawakami, Takeshi
    Tsushima, Takahiro
    Yasui, Hirofumi
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kawatani, Keisuke
    Yamazaki, Kentaro
    ONCOLOGIST, 2024,
  • [7] 5-fluorouracil in head and neck cancer patients: A population pharmacokinetics study.
    Mercier, C.
    Yang, C.
    Dahan, L.
    Ciccolini, J.
    Bagarry, D.
    Seitz, J. F.
    Favre, R. G.
    Lacarelle, B.
    Duffaud, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients
    Swartz, Justin E.
    Pothen, Ajit J.
    Wegner, Inge
    Smid, Ernst J.
    Swart, Karin M. A.
    de Bree, Remco
    Leenen, Loek P. H.
    Grolman, Wilko
    ORAL ONCOLOGY, 2016, 62 : 28 - 33
  • [9] Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
    C. D. A. Meerkerk
    N. Chargi
    P. A. de Jong
    F. van den Bos
    R. de Bree
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 967 - 977
  • [10] Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
    Meerkerk, C. D. A.
    Chargi, N.
    de Jong, P. A.
    van den Bos, F.
    de Bree, R.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (02) : 967 - 977
12345